or Try an Advanced Search...

    Technical Analysis for AKLI - Akili, Inc.

    Grade Last Price % Change Price Change
    D 0.43 4.68% 0.02
    AKLI closed down 0.29 percent on Wednesday, May 8, 2024, on 22 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical AKLI trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 4.68%
    Narrow Range Bar Range Contraction 4.68%
    Outside Day Range Expansion 4.68%
    Wide Bands Range Expansion 4.68%
    Gapped Up Strength 4.68%
    Spinning Top Other 4.37%
    Calm After Storm Range Contraction 4.37%
    NR7 Range Contraction 4.37%
    Narrow Range Bar Range Contraction 4.37%
    Inside Day Range Contraction 4.37%
    Older End-of-Day Signals for AKLI ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 1 hour ago
    Up 5% about 1 hour ago
    Up 3% about 1 hour ago
    60 Minute Opening Range Breakout about 2 hours ago
    Up 2% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    AKLI Chart by TradingView
    Basic chart:

    Profile

    Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Health Information Services
    Keywords: Retailing Retailers Neuropsychology Behavior Modification Digital Therapeutics

    Is AKLI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 30 Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results
    Feb 29 Earnings Scheduled For February 29, 2024
    Feb 28 Preview: Akili's Earnings
    Feb 27 PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
    Feb 26 Gold Moves Lower; Pilgrim's Pride Earnings Top Views
    Feb 26 Akili's ADHD device submitted for Japanese approval, stock rallies 130%
    Feb 26 Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan
    Feb 21 Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates
    Jan 15 Akili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
    Dec 29 Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years
    See more AKLI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.67
    52 Week Low 0.1912
    Average Volume 2,118,619
    200-Day Moving Average 0.51
    50-Day Moving Average 0.30
    20-Day Moving Average 0.30
    10-Day Moving Average 0.36
    Average True Range 0.04
    RSI (14) 68.15
    ADX 34.3
    +DI 39.35
    -DI 9.80
    Chandelier Exit (Long, 3 ATRs) 0.36
    Chandelier Exit (Short, 3 ATRs) 0.33
    Upper Bollinger Bands 0.46
    Lower Bollinger Band 0.14
    Percent B (%b) 0.84
    BandWidth 108.63
    MACD Line 0.04
    MACD Signal Line 0.02
    MACD Histogram 0.0184
    Fundamentals Value
    Market Cap 31.79 Million
    Num Shares 78.3 Million
    EPS -1.10
    Price-to-Earnings (P/E) Ratio -0.37
    Price-to-Sales 18.00
    Price-to-Book 0.27
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.43
    Resistance 3 (R3) 0.44 0.43 0.43
    Resistance 2 (R2) 0.43 0.42 0.43 0.43
    Resistance 1 (R1) 0.42 0.42 0.41 0.42 0.43
    Pivot Point 0.41 0.41 0.41 0.41 0.41
    Support 1 (S1) 0.40 0.40 0.39 0.40 0.39
    Support 2 (S2) 0.39 0.40 0.39 0.38
    Support 3 (S3) 0.38 0.39 0.38
    Support 4 (S4) 0.38